Occurrence of macroprolactinemia in schizophrenia patients treated with risperidone or amisulpride

ConclusionRisperidone and amisulpride caused hyperprolactinemia and macroprolactinemia; thus, detection of MPRL in the clinical setting should be performed as this phenomenon appears early in treatment (the second week) and continues, that can avoid unnecessary examination and treatment for asymptomatic patients with macroprolactinemia.

Source: Asia-Pacific Psychiatry - March 30, 2021 Category: Psychiatry Authors: Wang Zhenhua, Chen Haizhi, Li Jing, Fei Xiaocong, Li Jianhua, Liu Jianjun, Lei Lilei, Jin Haiying Tags: ORIGINAL ARTICLE Source Type: research